Retractable Technologies, Inc. (RVP)
0.576
-0.02
(-3.84%)
USD |
NYAM |
Nov 20, 14:03
Retractable Technologies Enterprise Value : -20.34M for Nov. 19, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 19, 2026 | -20.34M |
| November 18, 2026 | -19.71M |
| November 17, 2026 | -21.36M |
| November 16, 2026 | -21.51M |
| November 13, 2026 | -21.51M |
| November 12, 2026 | -21.66M |
| November 11, 2026 | -21.68M |
| November 10, 2026 | -21.69M |
| November 09, 2026 | -21.51M |
| November 06, 2026 | -21.35M |
| November 05, 2026 | -21.33M |
| November 04, 2026 | -21.33M |
| November 03, 2026 | -21.45M |
| November 02, 2026 | -21.33M |
| October 30, 2026 | -21.36M |
| October 29, 2026 | -21.02M |
| October 28, 2026 | -20.82M |
| October 27, 2026 | -20.65M |
| October 26, 2026 | -20.88M |
| October 23, 2026 | -20.88M |
| October 22, 2026 | -20.82M |
| October 21, 2026 | -20.88M |
| October 20, 2026 | -20.88M |
| October 19, 2026 | -20.97M |
| October 16, 2026 | -21.03M |
| Date | Value |
|---|---|
| October 15, 2026 | -20.67M |
| October 14, 2026 | -20.52M |
| October 13, 2026 | -20.01M |
| October 12, 2026 | -18.82M |
| October 09, 2026 | -18.42M |
| October 08, 2026 | -18.46M |
| October 07, 2026 | -17.60M |
| October 06, 2026 | -17.59M |
| October 05, 2026 | -17.46M |
| October 02, 2026 | -17.41M |
| October 01, 2026 | -17.62M |
| September 30, 2026 | -17.59M |
| September 29, 2026 | -17.95M |
| September 28, 2026 | -18.25M |
| September 25, 2026 | -17.86M |
| September 24, 2026 | -18.37M |
| September 23, 2026 | -18.01M |
| September 22, 2026 | -18.01M |
| September 21, 2026 | -17.56M |
| September 18, 2026 | -17.28M |
| September 17, 2026 | -17.72M |
| September 16, 2026 | -18.45M |
| September 15, 2026 | -18.45M |
| September 14, 2026 | -18.40M |
| September 11, 2026 | -18.45M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 207.35B |
| AngioDynamics, Inc. | 433.25M |
| Alphatec Holdings, Inc. | 1.596B |
| AtriCure, Inc. | 2.665B |
| Baxter International, Inc. | 19.15B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.360M |
| Revenue (Quarterly) | 14.13M |
| Total Expenses (Quarterly) | 16.49M |
| EPS Diluted (Quarterly) | -0.0807 |
| Gross Profit Margin (Quarterly) | 1.63% |
| Profit Margin (Quarterly) | -16.70% |
| Earnings Yield | -36.74% |
| Normalized Earnings Yield | -24.91 |